Drugs / YMN-136
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07409805 | Mar 2026 → Feb 2028 expected | colorectal cancer | West China Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YMN-136 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07409805 ↗ |
| Modality | Vaccine | “YMN-136 vaccine” NCT07409805 ↗ |
| Route | Intramuscular | “via intramuscular injection” NCT07409805 ↗ |